Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Vaccine
|
July 21, 2010
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
N De Carvalho, J Teixeira, C M Roteli-Martins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Clinical trials of cancer screening in the developing world and their impact on cancer healthcare
R Sankaranarayanan, C Sauvaget, K Ramadas, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 3, 2006
Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil
P Naud, J Matos, L Hammes, et al.
European Journal of Gynaecological Oncology
|
August 22, 2008
Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study
A Longatto-Filho, C Roteli-Martins, L Hammes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study
A Longatto-Filho, M Erzen, M Branca, et al.
International Journal of STD & AIDS
|
May 17, 2008
Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort
K Syrjänen, P Naud, S Derchain, et al.
Journal of Lower Genital Tract Disease
|
October 18, 2006
Cervical cancer screening in Porto Alegre, Brazil: alternative methods for detecting cancer precursors in a developing country
P Naud, J Matos, L Hammes, et al.
International Journal of STD & AIDS
|
June 18, 2011
Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening studies
K Syrjänen, I Shabalova, P Naud, et al.
Anticancer Research
|
August 17, 2005
Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study
K Syrjänen, P Naud, S Derchain, et al.
European Journal of Gynaecological Oncology
|
October 25, 2012
Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the NIS-LAMS cohort
K Syrjänen, I Shabalova, L Sarian, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Vaccine
|
July 21, 2010
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
N De Carvalho, J Teixeira, C M Roteli-Martins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Clinical trials of cancer screening in the developing world and their impact on cancer healthcare
R Sankaranarayanan, C Sauvaget, K Ramadas, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
January 3, 2006
Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil
P Naud, J Matos, L Hammes, et al.
European Journal of Gynaecological Oncology
|
August 22, 2008
Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study
A Longatto-Filho, C Roteli-Martins, L Hammes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 29, 2006
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study
A Longatto-Filho, M Erzen, M Branca, et al.
International Journal of STD & AIDS
|
May 17, 2008
Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort
K Syrjänen, P Naud, S Derchain, et al.
Journal of Lower Genital Tract Disease
|
October 18, 2006
Cervical cancer screening in Porto Alegre, Brazil: alternative methods for detecting cancer precursors in a developing country
P Naud, J Matos, L Hammes, et al.
International Journal of STD & AIDS
|
June 18, 2011
Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening studies
K Syrjänen, I Shabalova, P Naud, et al.
Anticancer Research
|
August 17, 2005
Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study
K Syrjänen, P Naud, S Derchain, et al.
European Journal of Gynaecological Oncology
|
October 25, 2012
Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the NIS-LAMS cohort
K Syrjänen, I Shabalova, L Sarian, et al.
Page
of 2